News Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m3967 (Published 13 October 2020) Cite this as: BMJ 2020;371:m3967 Article Related content Metrics Responses Peer review Related articles News Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated Published: 09 September 2020; BMJ 370 doi:10.1136/bmj.m3525 News Covid-19: Eli Lilly pauses antibody trial for safety reasons Published: 14 October 2020; BMJ 371 doi:10.1136/bmj.m3985 See more Housing and health: channel funding where it will bring the most benefit for all BMJ February 25, 2021, 372 n560; DOI: https://doi.org/10.1136/bmj.n560 GP academic can practise again after suspension for dishonesty is cut short BMJ February 25, 2021, 372 n563; DOI: https://doi.org/10.1136/bmj.n563 Covid-19: Judge caps costs that campaigners will have to pay for PPE court action BMJ February 25, 2021, 372 n566; DOI: https://doi.org/10.1136/bmj.n566 Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study BMJ February 25, 2021, 372 n567; DOI: https://doi.org/10.1136/bmj.n567 NHS and social care workforce planning is a “joke,” says former health secretary BMJ February 25, 2021, 372 n564; DOI: https://doi.org/10.1136/bmj.n564 Cited by... Covid-19: Eli Lilly pauses antibody trial for safety reasonsFulltext PDF
